Rwc Asset Management LLP Eli Lilly & CO Transaction History

Rwc Asset Management LLP

  • $1.38 Billion
  • Q3 2024

A detailed history of Rwc Asset Management LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Rwc Asset Management LLP holds 434 shares of LLY stock, worth $342,074. This represents 0.03% of its overall portfolio holdings.

Number of Shares
434
Previous 362 19.89%
Holding current value
$342,074
Previous $327,000 17.43%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$772.14 - $960.02 $55,594 - $69,121
72 Added 19.89%
434 $384,000
Q2 2024

Aug 01, 2024
BUY
$724.87 - $909.04 $262,402 - $329,072
362 New
362 $327,000
Q1 2019

May 13, 2019
SELL
$111.31 - $131.02 $5.32 Million - $6.27 Million
-47,824 Closed
0 $0
Q4 2018

Jan 30, 2019
SELL
$105.9 - $118.64 $11.6 Million - $13 Million
-109,329 Reduced 69.57%
47,824 $5.53 Million
Q3 2018

Oct 16, 2018
SELL
$85.86 - $107.31 $6.56 Million - $8.2 Million
-76,399 Reduced 32.71%
157,153 $16.9 Million
Q2 2018

Jul 27, 2018
SELL
$75.7 - $86.88 $1.69 Million - $1.94 Million
-22,373 Reduced 8.74%
233,552 $19.9 Million
Q1 2018

May 04, 2018
SELL
$74.21 - $87.6 $4.03 Million - $4.76 Million
-54,366 Reduced 17.52%
255,925 $19.8 Million
Q4 2017

Feb 07, 2018
SELL
$81.94 - $87.89 $3.81 Million - $4.08 Million
-46,474 Reduced 13.03%
310,291 $26.2 Million
Q3 2017

Nov 15, 2017
SELL
$77.07 - $85.54 $1.64 Million - $1.82 Million
-21,308 Reduced 5.64%
356,765 $30.5 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-59,741 Reduced 13.65%
378,073 $31.1 Million
Q1 2017

Apr 29, 2019
SELL
N/A
-275,895 Reduced 38.66%
437,814 $36.8 Million
Q4 2016

Apr 29, 2019
BUY
N/A
1,317 Added 0.18%
713,709 $52.5 Million
Q3 2016

Apr 29, 2019
BUY
N/A
25,429 Added 3.7%
712,392 $57.2 Million
Q2 2016

Apr 29, 2019
BUY
N/A
65,254 Added 10.5%
686,963 $54.1 Million
Q1 2016

Apr 29, 2019
SELL
N/A
-4,738 Reduced 0.76%
621,709 $44.8 Million
Q4 2015

Apr 29, 2019
BUY
N/A
58,853 Added 10.37%
626,447 $52.8 Million
Q3 2015

Apr 29, 2019
SELL
N/A
-27,526 Reduced 4.63%
567,594 $47.5 Million
Q2 2015

Apr 29, 2019
SELL
N/A
-137,601 Reduced 18.78%
595,120 $49.7 Million
Q1 2015

Apr 29, 2019
SELL
N/A
-29,456 Reduced 3.86%
732,721 $53.2 Million
Q4 2014

Apr 29, 2019
SELL
N/A
-4,551 Reduced 0.59%
762,177 $52.6 Million
Q3 2014

Apr 29, 2019
BUY
N/A
31,794 Added 4.33%
766,728 $49.7 Million
Q2 2014

Apr 29, 2019
BUY
N/A
734,934
734,934 $45.7 Million

Others Institutions Holding LLY

# of Institutions
4,007
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rwc Asset Management LLP Portfolio

Follow Rwc Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rwc Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rwc Asset Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email